Results
1
1 companies
argenx
Market Cap: €42.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€678.40
7D
-4.5%
1Y
28.6%
